Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

PD-98059

MEK inhibitor
 
BML-EI360-0005 5 mg 89.00 USD
Do you need bulk/larger quantities?
 
Replaces Prod. #: ALX-385-023

PD-98059 is a potent and selective inhibitor of MAP kinase kinase (MEK). It selectively blocks the activation of MEK thereby inhibiting the phosphorylation and the activation of MAP kinase. PD-98059 is cell permeable. In PC12 pheochromocytoma cells, it completely blocked the increase in MAP kinase activity produced by NGF, IC50=2µM. Enhances self-renewal of embryonic stem cells PD-98059 is an invaluable tool to help elucidate the role of the MAPK cascade in a variety of biological systems. Inhibits cell growth and proliferation in acute myelogenous leukemia cell lines by causing cell arrest.

Product Specification

Formula:C16N13NO3
 
MW:267.3
 
CAS:167869-21-8
 
Purity:≥95% (HPLC)
 
Appearance:Pale yellow solid
 
Solubility:Soluble in DMSO (6.5mg/ml); 25mg/ml in anhydrous DMSO), methanol, dichlormethane and 100% ethanol (0.6mg/ml).
 
Shipping:Ambient
 
Long Term Storage:-20°C
 
Handling:Protect from light.
 
Technical Info/Product Notes:Replacement for ADI-HPK-107
 
bml-ei360
Please mouse over
bml-ei360

Product Literature References

Additive effects of low concentrations of estradiol-17β and progesterone on nitric oxide production by human vascular endothelial cells through shared signaling pathways: Y. Pang & P. Thomas; J. Steroid Biochem. Mol. Biol. 165, 258 (2017), Application(s): Effects on NO regulation and production, Abstract;
Interleukin-1β and Tumor Necrosis Factor-α Synergistically Induce Expression of Colony Stimulating Factors in Synovial Fibroblasts from the Human Temporomandibular Joint: S. Watanabe, et al.; Int. J. Oral-Med. Sci. 15, 74 (2017), Full Text
Involvement of PI3K and PKA pathways in mouse tongue epithelial differentiation: J.K. Jung, et al.; Acta Histochem. 119, 92 (2017), Abstract;
AMPK activates LXRα and ABCA1 expression in human macrophages: M. Kemmerer, et al.; Int. J. Biochem. Cell Biol. 16, 30154 (2016), Application(s): Cell culture using human monocytic cells, Abstract;
Calcitonin gene-related peptide is a key factor in the homing of transplanted human MSCs to sites of spinal cord injury: Y. Zhang, et al.; Sci. Rep. 6, 27724 (2016), Application(s): Migration assay in Boyden chamber, Abstract; Full Text
All-Trans Retinoic Acid Induces Proliferation, Survival, and Migration in A549 Lung Cancer Cells by Activating the ERK Signaling Pathway through a Transcription-Independent Mechanism: R.S. Quntero Barceinas, et al.; BioMed Res. Int. 2015, Article ID 404368 (2015), Application(s): Cell Culture, Abstract; Full Text
Amphiregulin may be a new biomarker of classically activated macrophages: C. Meng, et al.; Biochem. Biophys. Res. Commun. 466, 393 (2015), Application(s): Cell Culture, Abstract;
Cross Talk Between Androgen Receptor/ Filamin A And TrkA Regulates Neurite Outgrowth In PC12 Cells: M. Di Donato, et al.; Mol. Biol. Cell 26, 2858 (2015), Application(s): Cell Culture, Abstract; Full Text
CXCR4 inhibitor attenuates allergen-induced lung inflammation by down-regulating MMP-9 and ERK1/2: H. Chen, et al. ; Int. J. Clin. Exp. Pathol. 8, 6700 (2015), Application(s): Cell Culture, Abstract; Full Text
Glycated albumin triggers fibrosis and apoptosis via an NADPH oxidase/Nox4-MAPK pathway-dependent mechanism in renal proximal tubular cells: W. Qi, et al.; Mol. Cell. Endocrinol. 405, 74 (2015), Application(s): Cell Culture, Abstract;
Mechanism of Macrophage-Derived Chemokine/CCL22 Production by HaCaT Keratinocytes: C. Yano, et al.; Ann. Dermatol. 27, 152 (2015), Application(s): Cell Culture, Abstract; Full Text
Phloretin ameliorates chemokines and ICAM-1 expression via blocking of the NF-κB pathway in the TNF-α-induced HaCaT human keratinocytes: W.C. Huang, et al.; Int. Immunopharmacol. 27, 32 (2015), Application(s): Cell Culture, Western Blot, Abstract;
Vinpocetine Inhibits Streptococcus pneumoniae-Induced Upregulation of Mucin MUC5AC Expression via Induction of MKP-1 Phosphatase in the Pathogenesis of Otitis Media: J.Y. Lee, et al.; J. Immunol. 194, 5990 (2015), Application(s): Cell Culture, Abstract; Full Text
Pathobiology of renal-specific oxidoreductase/myo-inositol oxygenase in diabetic nephropathy: its implications in tubulointerstitial fibrosis: P. Xie, et al.; Am. J. Physiol. Renal Physiol. 298, F1393 (2010), Abstract; Full Text
IL-4-induced priming of human intestinal mast cells for enhanced survival and Th2 cytokine generation is reversible and associated with increased activity of ERK1/2 and c-Fos: A. Lorentz, et al.; J. Immunol. 174, 6751 (2005), Abstract;
A phosphatidylinositol 3-kinase inhibitor induces a senescent-like growth arrest in human diploid fibroblasts: M. Tresini, et al.; Cancer Res. 58, 1 (1998), Abstract;
Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production: F.J. Dumont et al.; J Immunol 160, 2579 (1998), Abstract;
A synthetic inhibitor of the mitogen-activated protein kinase cascade: D.T. Dudley, et al.; PNAS 92, 7686 (1995), Abstract;
Desensitization of Ras activation by a feedback disassociation of the SOS-Grb2 complex: S.B. Waters, et al.; J. Biol. Chem. 270, 20883 (1995), Abstract;
Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor: L. Pang, et al.; J. Biol. Chem. 270, 13585 (1995), Abstract;
Negative feedback regulation and desensitization of insulin- and epidermal growth factor-stimulated p21ras activation: W.J. Langlois, et al.; J. Biol. Chem. 270, 25320 (1995), Abstract;
PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo: D. Alessi, et al.; J. Biol. Chem. 270, 27489 (1995), Abstract;

Related Literature

Brochures
Stem Cells
Stem Cells
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,